Clinical trial

Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a…

NCT00118326 · Fred Hutchinson Cancer Center, Other · Completed

Key facts

NCT number NCT00118326
Title Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease
Official title Feasibility of Granulocyte-Colony Stimulating Factor (G-CSF) Stimulated Bone Marrow From Pediatric Donors as a Stem Cell Source for Allogeneic Bone Marrow Transplant
Lead sponsor Fred Hutchinson Cancer Center, Other
Status Completed
Phase Phase 1/Phase 2
Study type Interventional
Conditions Kidney Cancer, Leukemia, Lymphoma, Myelodysplastic Syndromes, Neuroblastoma, Sarcoma
Intervention type Biological, Procedure
Interventions filgrastim, allogeneic bone marrow transplantation
Start date Aug 1, 2003
Completion May 1, 2007
First posted Jul 11, 2005
Last update posted May 14, 2010
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies